Chemoembolization Plus Microwave Ablation vs Chemoembolization Alone in Unresectable Hepatocellular Carcinoma Beyond the Milan Criteria: A Propensity Scoring Matching Study-Reference-Cited by-同舟云学术

Chemoembolization Plus Microwave Ablation vs Chemoembolization Alone in Unresectable Hepatocellular Carcinoma Beyond the Milan Criteria: A Propensity Scoring Matching Study

Published:2021-11 Issue: Volume:Volume 8 Page:1311-1322
ISSN:2253-5969
Container-title:Journal of Hepatocellular Carcinoma
language:en
Short-container-title:JHC

Author:

Li Hui-Zhou^ORCID,Tan Jie^ORCID,Tang Tian,An Tian-Zhi,Li Jun-Xiang,Xiao Yu-Dong^ORCID

Publisher

Informa UK Limited

Subject

General Medicine

Reference36 articles.

1. Hepatocellular carcinoma

2. European Assoc Study Liver. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69:182–236.

3. Critical review of HCC imaging in the multidisciplinary setting: treatment allocation and evaluation of response

4. Transarterial Radioembolization for Hepatocellular Carcinoma with Major Vascular Invasion: A Nationwide Propensity Score–Matched Analysis with Target Trial Emulation

5. Hepatectomy, RFA, and Other Liver Directed Therapies for Treatment of Breast Cancer Liver Metastasis: A Systematic Review

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2023 Update of Indian National Association for Study of the Liver Consensus on Management of Intermediate and Advanced Hepatocellular Carcinoma: The Puri III Recommendations;Journal of Clinical and Experimental Hepatology;2024-01

2. Microwave ablation combined with transarterial chemoembolization containing doxorubicin hydrochloride liposome for treating primary and metastatic liver cancers;Journal of Interventional Medicine;2023-08

3. Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Chinese perspective;Clinical and Molecular Hepatology;2023-04-01

4. Microwave ablation and synchronous transarterial chemoembolization combined with PD-1 inhibitor in patients with hepatocellular carcinoma following tyrosine kinase inhibitor intolerance;Frontiers in Immunology;2023-01-10

5. Current Status of Ablation Therapy for Primary Liver Cancer;Advances in Clinical Medicine;2023